Scientific Committee
Title:
Transforming Precision Oncology: The INT²GRATE Consortium’s Novel Approach to Determining Clinical Actionability in the Cancer GenomeBiography
Dr. Ghazani is the Director of Clinical Genomics at Brigham Genomic Medicine, a faculty member at Harvard Medical School and a geneticist at Brigham and woman’s Hospital. Dr. Ghazani’s interests include the integration of somatic and germline interpretation of cancer data. She investigates the relationship between hereditary and non-hereditary genomic variants and their effects on tumorigenicity and medical management. She received her M.Sc. and Ph.D. degrees from the University of Toronto and completed her medical genetics fellowship at Harvard Medical School and research fellowship at Massachusetts General Hospital. She is board-certified by the American Board of Medical Genetics and Genomics.
